Statement Of Financial Position [Abstract]

Cinclus Pharma Holding AB - Filing #5879290

Concept	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31
Statement of financial position [abstract]
Assets [abstract]
Right-of-use assets	—	—	500,000 SEK	—	—	—	—	—	—	249,000 SEK	—	—	—	—	—
Cash and cash equivalents	—	—	566 716 SEK	—	—	—	—	—	—	87 972 SEK	173 546 SEK	—	—	—	—
Assets	—	—	601 013 SEK	—	—	—	—	—	—	94 413 SEK	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	—	—	920,000 SEK	—	—	—	—	—	—	509,000 SEK	—	—	—	—	—
Retained earnings	—	—	771 997 SEK	—	—	—	—	—	—	606 837 SEK	—	—	—	—	—
Equity	771 997 SEK	1 297 740 SEK	555 330 SEK	920,000 SEK	28 667 SEK	509,000 SEK	26 004 SEK	503 524 SEK	606 837 SEK	76 800 SEK	126 874 SEK	509,000 SEK	16 837 SEK	394 163 SEK	503 691 SEK
Liabilities [abstract]
Liabilities	—	—	45 683 SEK	—	—	—	—	—	—	171 213 SEK	—	—	—	—	—
Equity and liabilities	—	—	601 013 SEK	—	—	—	—	—	—	94 413 SEK	—	—	—	—	—